About Us
- Contact Us
Our Technology
Our Science
- Pipeline
- Advantages of Gylden’s Candidates
News and Events
Menu Menu

You are here: Home1 / Conferences2 / New approach: MHC class I peptide libraries for the treatment of viral...

New approach: MHC class I peptide libraries for the treatment of viral and bacterial infectious diseases by innovative multi-epitope T cell adaptive vaccines

13th February 2025

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

/wp-content/uploads/2024/10/CompanyName-300x300.png 0 0 gatekeeper /wp-content/uploads/2024/10/CompanyName-300x300.png gatekeeper2025-02-13 13:46:152025-02-13 14:09:54New approach: MHC class I peptide libraries for the treatment of viral and bacterial infectious diseases by innovative multi-epitope T cell adaptive vaccines

© Gylden Pharma

Website maintained by Digital Trading

Contact Us

Rapid Emergex Antigen Deployment Initiative (READI): a synthetic T cell vaccine...Using targeted mass spectrometry to characterize the mechanism of action for...